Pages that link to "Q49218095"
Jump to navigation
Jump to search
The following pages link to Gut hormone polyagonists for the treatment of type 2 diabetes (Q49218095):
Displaying 11 items.
- Unravelling the role and mechanism of adipokine and gastrointestinal signals in animal models in the nonhomeostatic control of energy homeostasis: Implications for binge eating disorder (Q57045879) (← links)
- Pathogenesis of Nonalcoholic Steatohepatitis and Hormone-Based Therapeutic Approaches (Q58705640) (← links)
- Future Perspectives on GLP-1 Receptor Agonists and GLP-1/glucagon Receptor Co-agonists in the Treatment of NAFLD (Q59136513) (← links)
- Targeting the Incretin/Glucagon System With Triagonists to Treat Diabetes (Q89113530) (← links)
- Multiagonist Unimolecular Peptides for Obesity and Type 2 Diabetes: Current Advances and Future Directions (Q89940067) (← links)
- GLP-1: Molecular mechanisms and outcomes of a complex signaling system (Q90016044) (← links)
- Glucagon, GLP-1 and Thermogenesis (Q92129722) (← links)
- Incretin Mimetics as Rational Candidates for the Treatment of Traumatic Brain Injury (Q92513493) (← links)
- The Effects of Dual GLP-1/GIP Receptor Agonism on Glucagon Secretion-A Review (Q92825152) (← links)
- Nonclassical Islet Peptides: Pancreatic and Extrapancreatic Actions (Q95268316) (← links)
- G protein-coupled receptors: structure- and function-based drug discovery (Q104795034) (← links)